Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies

PURPOSE: To assess the pharmacokinetics and safety of hydrochloride ophthalmic solution 0.77% olopatadine from 2 independent (Phase I and Phase III, respectively) clinical studies in healthy subjects. MATERIALS AND METHODS: The Phase I, multicenter, randomized (2:1), vehicle-controlled study was con...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Ophthalmol
Autors principals: Meier, Edward, Narvekar, Abhijit, Iyer, Ganesh R, DuBiner, Harvey B, Vutikullird, Apinya, Wirta, David, Sall, Kenneth
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2017
Matèries:
Clinical Trial Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5391828/
https://ncbi.nlm.nih.gov/pubmed/28435218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S126690
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars